Views & Analysis Medical meetings: Blockbuster or Netflix? Paul Tunnah asks whether medical meetings will remain relevant in a digital world, and how they might adapt.
Deep Dive Did cancer clinical trials stay on track at ASCO 2019? Chicago is recovering after 40,000 oncologists and cancer experts descended on the city for this year’s ASCO conference.
Views & Analysis As cancer treatments evolve, so must investment mechanisms Last month’s American Society of Clinical Oncology (ASCO) meeting kicked off with a presentation from Professor Ruth Plummer, a medical oncologist from Newcastle in the UK who, in 2003, was
Views & Analysis On the pulse of ASCO: pricing and clinical trial access New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO.
Views & Analysis Digital health technology has the potential to transform can... Digital and connected health technology has real potential to transform cancer care, writes Piotr Wnuk.
News Makary confirmed as Trump's FDA pick, with Weldon for CDC Martin Makary has been confirmed as Donald Trump's pick for FDA Commissioner, while Dave Weldon has been selected as his pick for CDC Director
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
